JPRN-UMIN000047032已完成未知
Humoral response after BNT162b2 vaccination in Japanese hemodialysis patients - Effectiveness of BNT162b2 vaccine in Japanese hemodialysis patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 294
研究概览
简要总结
Following vaccination, 97.6% of the hemodialysis group and 100% of the control group were positive for the anti-spike antibody. The median level of anti-spike antibody was 2,728.7 AU/mL (IQR, 1,024.2-7,688.2 AU/mL) in the hemodialysis group and 10,500 AU/ml (IQR, 9,346.1-2,4500 AU/mL) in the health care workers group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have had COVID-19 in the past
研究者
相似试验
已完成
Unknown
Humoral response after BNT162b2 vaccine in Japanese of hemodialysis patientsHemodialysis patientsJPRN-UMIN000046999Fujita Memorial Hospital185
已完成
Unknown
Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patientsCOVID-19 in hemodialysis patientsJPRN-UMIN000049684Fujita Memorial Hospital, Internal Medicine294
已完成
不适用
Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 VaccineCOVID-19 VaccinesHemodialysis ComplicationNCT04881396Hospices Civils de Lyon99
已完成
不适用
Multicenter Clinical Study on the Safety and Efficacy of Nilotinib Discontinuation in Patients with Chronic Myelogenous Leukemia-Chronic Phase and Complete Molecular ResponseChronic Myelogenous LeukemiaJPRN-UMIN000005904Akita university and the NPO Tohoku Hematology Expert Meeting100
已完成
不适用
Hiroshima NT-proBNP study in hemodialysis patients (HINT)end stage renal failureJPRN-UMIN000007656Department of Nephrology, Hiroshima University Hospital1,000